Efficiency of a Whole Body Vibration Training Program in Adult Renal Transplanted Patients
NCT ID: NCT03120377
Last Updated: 2017-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2017-03-02
2017-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whole Body Vibration Versus Aerobic Training on Interleukin 6 and Endurance After Renal Transplantation
NCT07333105
Effect of Whole-body Vibration Training in Patients With Renal Dialysis
NCT07049718
Cross-training Effect of Whole-body Vibration
NCT03750799
Whole Body Vibration in Individuals Submitted to ACL
NCT02609971
Immediate Effects of Whole Body Vibration on Neuromuscular Performance of Quadriceps Femoris and Balance
NCT02416362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Platform group
Group submitted to the whole body vibration training program
Platform
Whole body vibration training will consist of 12 consecutive weeks with two sessions per week on alternate days. Initially, before training with the vibratory platform, stretches lasting 5 to 10 minutes will be performed, with a series of 60 seconds for each of the following muscle groups: pectorals, sternocleidomastoids, scalenes, quadriceps and ischiatibial muscles. Patients will be monitored through vital signs for follow-up.
Platform sham group
Group that will receive the whole body vibration simulation treatment without the therapeutic effect of the platform, but with vibrating platform connected with the display on and a sound device coupled with vibration-generated noise recording, but without therapeutic purposes.
Platform sham
will receive the treatment without the therapeutic effect of the platform, but with vibrating platform connected with the display lit and a sound device coupled with a noise recording generated by the vibration, but without therapeutic purposes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platform
Whole body vibration training will consist of 12 consecutive weeks with two sessions per week on alternate days. Initially, before training with the vibratory platform, stretches lasting 5 to 10 minutes will be performed, with a series of 60 seconds for each of the following muscle groups: pectorals, sternocleidomastoids, scalenes, quadriceps and ischiatibial muscles. Patients will be monitored through vital signs for follow-up.
Platform sham
will receive the treatment without the therapeutic effect of the platform, but with vibrating platform connected with the display lit and a sound device coupled with a noise recording generated by the vibration, but without therapeutic purposes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stable graft function (creatinine \<1.8 mg / dL)
* hemoglobin\> 8g / dL
* age range 18 And 59
* both sexes
Exclusion Criteria
* Patients with neurological, diagnosed or pulmonary heart disease
* Involved in some physiotherapeutic program
* With hospitalization history for 3 months
* Pregnant
* Current or previous smokers
* That use pacemaker, screws and / or pins in the body
* Presence of acute migraines, labyrinthitis
* History of thrombosis
* Body weight greater than 120Kg
* Cognitive, visual and / or auditory deficits
* Osteomioarticular diseases that would impair evaluation procedures and / or training
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Pernambuco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lívia Gomes da Rocha
physiotherapist of the post-graduation program in physiotherapy of the Federal University of Pernambuco, principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lívia Rocha
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal de Pernambuco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratório Cardiopulmonar
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LRocha
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.